Dual modulation of cell survival and cell death by β <sub>2</sub> -adrenergic signaling in adult mouse cardiac myocytes
-
- Wei-Zhong Zhu
- Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
-
- Ming Zheng
- Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
-
- Walter J. Koch
- Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
-
- Robert J. Lefkowitz
- Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
-
- Brian K. Kobilka
- Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
-
- Rui-Ping Xiao
- Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; Department of Surgery and Department of Medicine and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710; and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA 94305
抄録
<jats:p> The goal of this study was to determine whether β <jats:sub>1</jats:sub> -adrenergic receptor (AR) and β <jats:sub>2</jats:sub> -AR differ in regulating cardiomyocyte survival and apoptosis and, if so, to explore underlying mechanisms. One potential mechanism is that cardiac β <jats:sub>2</jats:sub> -AR can activate both G <jats:sub>s</jats:sub> and G <jats:sub>i</jats:sub> proteins, whereas cardiac β <jats:sub>1</jats:sub> -AR couples only to G <jats:sub>s</jats:sub> . To avoid complicated crosstalk between β-AR subtypes, we expressed β <jats:sub>1</jats:sub> -AR or β <jats:sub>2</jats:sub> -AR individually in adult β <jats:sub>1</jats:sub> /β <jats:sub>2</jats:sub> -AR double knockout mouse cardiac myocytes by using adenoviral gene transfer. Stimulation of β <jats:sub>1</jats:sub> -AR, but not β <jats:sub>2</jats:sub> -AR, markedly induced myocyte apoptosis, as indicated by increased terminal deoxynucleotidyltransferase-mediated UTP end labeling or Hoechst staining positive cells and DNA fragmentation. In contrast, β <jats:sub>2</jats:sub> -AR (but not β <jats:sub>1</jats:sub> -AR) stimulation elevated the activity of Akt, a powerful survival signal; this effect was fully abolished by inhibiting G <jats:sub>i</jats:sub> , G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> , or phosphoinositide 3 kinase (PI3K) with pertussis toxin, βARK-ct (a peptide inhibitor of G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> ), or LY294002, respectively. This indicates that β <jats:sub>2</jats:sub> -AR activates Akt via a G <jats:sub>i</jats:sub> -G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> -PI3K pathway. More importantly, inhibition of the G <jats:sub>i</jats:sub> -G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> -PI3K-Akt pathway converts β <jats:sub>2</jats:sub> -AR signaling from survival to apoptotic. Thus, stimulation of a single class of receptors, β <jats:sub>2</jats:sub> -ARs, elicits concurrent apoptotic and survival signals in cardiac myocytes. The survival effect appears to predominate and is mediated by the G <jats:sub>i</jats:sub> -G <jats:sub>β</jats:sub> <jats:sub>γ</jats:sub> -PI3K-Akt signaling pathway. </jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 98 (4), 1607-1612, 2001-02-13
Proceedings of the National Academy of Sciences
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1363107369651552128
-
- NII論文ID
- 80012204640
-
- ISSN
- 10916490
- 00278424
-
- データソース種別
-
- Crossref
- CiNii Articles